Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Mirae Asset BSE Midcap 150 Momentum 30 ETF
[Equity: Thematic]  
 
Fund Details
Fund Type Growth Launch Date 16-Jul-26
Corpus(Cr.) 78.00 Latest NAV 12.1853 As on 29-10-2026
Equity(%) 99.98 52 Week High 13.2884
Debt(%) 0.02 52 Week Low 10
Others(%) 0.00 Exit Load 0
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Midcap 150 Momentum 30 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Akshay Udeshi
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate returns, before expenses, that are commensurate with the performance of the BSE Midcap 150 Momentum 30 Total Return Index, subject to tracking error.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 25.89%
Top 10 Holdings 49.29%
Top 25 Holdings 92.45%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 19.87
Pharma & Biotech 16.4
Electricals 15.55
Automobile 9.71
Industrial Products 5.64
Metals 5.3
Technology 4.64
Telecom 4.29
Finance & Investments 4.21
Retail 3.99
Food Beverage & Tobacco 3.06
Agricultural & Farm Machinery 2.84
Ferrous Metals 2.47
Software & Services 2.01
Cash 0.02
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.04
PE Ratio 27.12
 
Top 25 Holdings
Holdings Net Asset(%)
Laurus Labs Limited 5.38
Multi Commodity Exchange of India Ltd 5.19
Aurobindo Pharma Ltd. 5.18
Bharat Forge Ltd 5.11
Bharat Heavy Electricals Ltd. 5.03
AU Small Finance Bank Limited 5.03
Federal Bank Ltd. 4.84
One 97 Communications Limited 4.64
Sona BLW Precision Forgings Limited 4.60
VODAFONE IDEA LIMITED 4.29
FSN E-Commerce Ventures Limited 3.99
GE Vernova T&D India Limited 3.77
National Aluminium Co. Ltd. 3.59
APL Apollo Tubes Limited 3.49
CG Power and Industrial Solutions Limited 3.45
HITACHI ENERGY INDIA LIMITED 3.30
Radico Khaitan Ltd. 3.06
Ashok Leyland Ltd. 2.84
Aditya Birla Capital Ltd 2.56
Steel Authority of India Ltd. 2.47
Glenmark Pharmaceuticals ltd 2.28
KEI Industries Ltd. 2.15
TREPS 2.14
Ipca Laboratories Ltd. 2.06
Oracle Financial Services Software Limited 2.01

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-2.38% -2.76% 0.00% 0.00%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [BSE Midcap 150 Momentum 30]
-2.40% -3.16% 0.84% 0.00%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
0.00% 0.00% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
0.00% 0.00% 0.00% 0.00%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection